日出東方(603366.SH)擬2027萬元收購日出東方阿康桑馬克45%股權
格隆匯4月2日丨日出東方(603366.SH)公佈,公司和ARCON-SUNMARKA/S(丹麥阿康桑馬克公司,以下簡稱“轉讓方”)目前各持有日出東方阿康桑馬克大型太陽能系統工程技術有限公司(以下簡稱“日出東方阿康桑馬克”)55%和45%的股權。
為進一步加強對日出東方阿康桑馬克的統籌管理,提高整體經營效率,推動公司太陽能等清潔能源採暖產業的發展,經協商,日出東方擬以自有資金出資人民幣2027萬元收購轉讓方持有的日出東方阿康桑馬克45%的股權。收購完成後,日出東方阿康桑馬克將變為日出東方的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.